Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Biology » Proteins » Serpins and Protein Kinase Inhibitors: Novel Functions, Structural Features and Molecular Mechanisms Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Brain, Body, Cognition - A continuation of Functional Neurology, Rehabilitation and Ergonomics
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Rho-Kinase Inhibitor in Kidney Disease pp.63-88
Tell A Friend
Tell someone you know about this product.
Rho-Kinase Inhibitor in Kidney Disease pp.63-88 $100.00
Authors:  (Toshio Nishikimi - Dept. of Hypertension and Cardiorenal Medicine, Dokkyo Medical Univ., Mibu, Japan)
Recent studies demonstrated the importance of small GTP binding protein in physiological function. Rho, a member of small GTP binding protein, is known to function as a molecular switch in various cellular functions, including contraction, actin cytoskeleton organization, cell adhesion and motility, proliferation, cytokinesis, and gene expression. Among the Rho effectors, the cellular function and signal transduction of Rho-kinase have been extensively studied. However, the information about in vivo function is still limited until a specific inhibitor of Rho-kinase such as Y-27632 and fasudil was discovered. Rho-kinase inhibitor is a very powerful tool for examining the role of the Rho/Rho-kinase pathway in vitro and in vivo. Recent studies have demonstrated that Rho/Rho-kinase pathway is involved in the pathogenesis of various cardiovascular diseases such as arteriosclerosis, hypertension, angina pectoris, myocardial infarction, and pulmonary hypertension. However, there are few studies, which investigated the role of Rho/Rho-kinase in renal disease. Here we review the information about the therapeutic importance of the Rho/Rho-kinase pathway in renal disease. Specifically, we describe the recent our results about beneficial effect of Rho-kinase inhibitor on the glomerulosclerosis in hypertensive nephropathy. Our results suggest that chronic inhibition of Rho-kinase pathway may be a new therapeutic approach for the hypertensive glomerulosclerosis. Our results also suggest that the possible mechanism of renoprotective effect of Rho-kinase inhibitor is mediated via many pathways, including inhibition of extracellular matrix gene expression, monocytes/macrophages infiltration, and oxidative stress, and upregulation of eNOS gene expression. 

Available Options:
This Item Is Currently Unavailable.
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Rho-Kinase Inhibitor in Kidney Disease pp.63-88